Skip to content

Evaluation of benign and malignant renal tumors by shear wave elastography combined with contrast-enhanced ultrasound

Evaluation of benign and malignant renal tumors by shear wave elastography combined with contrast-enhanced ultrasound

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063463
Enrollment
Unknown
Registered
2022-09-07
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumor

Interventions

Index test:Shear wave elastography, Contrast-enhanced ultrasound, Mindray ultrasound machine

Sponsors

The Third Medical Center of the Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-85 years; 2. Patients with renal masses who have completed contrast-enhanced ultrasound with Sonovue; 3. If the patients are female, they should be non-pregnant and lactating women; 4. Patients with renal mass who are scheduled to undergo puncture biopsy or resection of the lesion; 5. Normal or manageable blood pressure (< 140/90 mmHg); 6. No previous treatment for local renal disease; 7. Patients voluntarily joined the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart disease or severe lung disease; 2. Pregnant, possibly pregnant or breastfeeding patients; 3. Patients with hydronephrosis and urinary tract obstruction; 4. Patients with cystic lesions in renal masses; 5. According to the judgment of the researchers, patients who are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Elastic value of renal tumor;Perfusion;Pseudocapsule sign;Enhancement mode;Intensity at peak time;Homogeneity;

Secondary

MeasureTime frame
Margin;

Countries

China

Contacts

Public ContactGao Yongyan

The Third Medical Center of the Chinese People's Liberation Army General Hospital

gaoyongyan7@163.com+86 18910900177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026